Adverse Event Severity Clause Samples
The Adverse Event Severity clause defines how the seriousness of adverse events is classified within the context of an agreement, typically in clinical trials or research studies. It establishes a standardized scale or criteria for rating the intensity of negative medical occurrences, such as mild, moderate, or severe, often referencing established medical guidelines or protocols. By providing a clear framework for categorizing adverse events, this clause ensures consistent reporting and assessment, which is essential for regulatory compliance and effective risk management.
Adverse Event Severity. The term “severe” is used to describe the intensity of an AE; the event itself could be of relatively minor clinical significance (e.g., “severe” headache). This is not the same as a “serious” AE. The severity of the AE will be graded by the Investigator according to the NCI CTCAE Grading Scale, v5.0 (the NCI CTCAE files can be accessed online at the following URL: ▇▇▇▇://▇▇▇.▇▇▇.▇▇▇.▇▇▇/ftp1/CTCAE/About.html). Events that are not specifically defined in CTCAE v5.0 should be assessed according to the guidance provided on page 2 of the CTCAE v5.0 document
Adverse Event Severity. The severity of the AE will be graded by the Investigator according to the NCI CTCAE Grading Scale, v. 4.03 (the NCI CTCAE files can be accessed online at the following URL: ▇▇▇▇://▇▇▇.▇▇▇.▇▇▇.▇▇▇/ftp1/CTCAE/About.html). If NCI CTCAE grading does not exist for an AE, the severity will be characterized as “mild,” “moderate,” “severe,” or “life-threatening (corresponding to Grades 1 to 4) according to the following definitions: • Mild events are usually transient and do not interfere with the patient’s daily activities. • Moderate events introduce a low level of inconvenience or concern to the patient and may interfere with daily activities. • Severe events interrupt the patient’s usual daily activities. • Life-threatening.
Adverse Event Severity. The term “severe” is used to describe the intensity of an AE; the event itself could be of relatively minor clinical significance (e.g., ‘severe’ headache). This is not the same as a “serious” AE. The severity of the AE will be graded by the Investigator according to the NCI CTCAE Grading Scale, v. 5.0 (the NCI CTCAE files can be accessed online at the following URL: ▇▇▇▇://▇▇▇.▇▇▇.▇▇▇.▇▇▇/ftp1/CTCAE/About.html). If there is not a specific NCI CTCAE grading scale for an AE, the severity will be characterized as mild, moderate, severe, or life-threatening, according to the following definitions: • Grade 1 (mild) events are usually transient in nature and do not interfere with the patient’s daily activities. • Grade 2 (moderate) events introduce a low level of inconvenience or concern to the patient and may interfere with daily activities. • Grade 3 (severe) events interrupt the patient’s usual daily activities. • Grade 4 events are those that are considered to be life-threatening.